SCHEMBL1995637

SCHEMBL1995637

CN1CCOC(Cn2cc(C3=C(c4c[nH]c5ccsc45)C(=O)NC3=O)c3ccccc32)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 12/20 0.57
PRKACB P22694 11/20 0.57
PRKACG P22612 10/20 0.57
PRKCB P05771 9/20 0.50
PRKCA P17252 9/20 0.50
PRKCG P05129 8/20 0.50
PRKCD Q05655 7/20 0.50
PRKCH P24723 6/20 0.50
CAMK2D Q13557 5/20 0.47
SIRT2 Q8IXJ6 2/20 0.47
PRKCE Q02156 7/20 0.45
GSK3B P49841 6/20 0.45
CDK4 P11802 4/20 0.45
PRKCZ Q05513 4/20 0.45
CCND1 P24385 3/20 0.45
PIM1 P11309 3/20 0.45
PRKCQ Q04759 3/20 0.45
SRC P12931 2/20 0.45
CAMK2B Q13554 2/20 0.45
CAMK2G Q13555 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989905 0.88 PRKACA (0.55) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1994510 0.85 PRKACA (0.48) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1990920 0.85 CAMK2D (0.47) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1993325 0.83 PRKACA (0.58) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1993499 0.81 PRKACA (0.57) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1990585 0.80 PRKACA (0.56) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1997192 0.80 PRKACA (0.56) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1992778 0.80 PRKACA (0.54) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1990909 0.79 PRKACA (0.57) PRKACAPRKACBPRKACGPRKCBPRKCA
SCHEMBL1991464 0.79 PRKACA (0.55) PRKACAPRKACBPRKACGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKACA 947/4885PRKACB 1285/4885PRKACG 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.